Beam Therapeutics (BEAM) Earnings Date & Reports

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BEAM is expected to report earnings to fall 9.68% to -112 cents per share on August 12

Beam Therapeutics BEAM Stock Earnings Reports

Q2'25

Est.

$-1.12

Q1'25

Missed

by $0.03

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.02

The last earnings report on May 06 showed earnings per share of -124 cents, missing the estimate of -121 cents. With 962.38K shares outstanding, the current market capitalization sits at 1.69B.

View a ticker or compare two or three

Compare

BEAM